Chapter 1: Introduction
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Landscape
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power Among Buyers
3.4. Market Share Analysis/Top Player Positioning
3.4.1. Market Share Analysis/Top Player Positioning 2020
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. Covid-19 Impact Analysis
Chapter 4: Opioids Market, by Product Type
4.1. Market Overview
4.1.1 Market Size and Forecast, by Product Type
4.2. Fentanyl
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Share Analysis, by Country
4.3. Oxycodone
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Share Analysis, by Country
4.4. Methadone
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Share Analysis, by Country
4.5. Morphine
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, by Region
4.5.3. Market Share Analysis, by Country
4.6. Hydrocodone
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, by Region
4.6.3. Market Share Analysis, by Country
4.7. Others
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, by Region
4.7.3. Market Share Analysis, by Country
Chapter 5: Opioids Market, by Application
5.1. Market Overview
5.1.1 Market Size and Forecast, by Application
5.2. Pain Management
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, by Region
5.2.3. Market Share Analysis, by Country
5.3. Cough Treatment
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, by Region
5.3.3. Market Share Analysis, by Country
5.4. Diarrhea Treatment
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, by Region
5.4.3. Market Share Analysis, by Country
Chapter 6: Opioids Market, by Region
6.1. Market Overview
6.1.1 Market Size and Forecast, by Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, by Product Type
6.2.3. Market Size and Forecast, by Application
6.2.4. Market Size and Forecast, by Country
6.2.5. U. S. Opioids Market
6.2.5.1. Market Size and Forecast, by Product Type
6.2.5.2. Market Size and Forecast, by Application
6.2.6. Canada Opioids Market
6.2.6.1. Market Size and Forecast, by Product Type
6.2.6.2. Market Size and Forecast, by Application
6.2.7. Mexico Opioids Market
6.2.7.1. Market Size and Forecast, by Product Type
6.2.7.2. Market Size and Forecast, by Application
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, by Product Type
6.3.3. Market Size and Forecast, by Application
6.3.4. Market Size and Forecast, by Country
6.3.5. Germany Opioids Market
6.3.5.1. Market Size and Forecast, by Product Type
6.3.5.2. Market Size and Forecast, by Application
6.3.6. France Opioids Market
6.3.6.1. Market Size and Forecast, by Product Type
6.3.6.2. Market Size and Forecast, by Application
6.3.7. Uk Opioids Market
6.3.7.1. Market Size and Forecast, by Product Type
6.3.7.2. Market Size and Forecast, by Application
6.3.8. Italy Opioids Market
6.3.8.1. Market Size and Forecast, by Product Type
6.3.8.2. Market Size and Forecast, by Application
6.3.9. Spain Opioids Market
6.3.9.1. Market Size and Forecast, by Product Type
6.3.9.2. Market Size and Forecast, by Application
6.3.10. Rest of Europe Opioids Market
6.3.10.1. Market Size and Forecast, by Product Type
6.3.10.2. Market Size and Forecast, by Application
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, by Product Type
6.4.3. Market Size and Forecast, by Application
6.4.4. Market Size and Forecast, by Country
6.4.5. Japan Opioids Market
6.4.5.1. Market Size and Forecast, by Product Type
6.4.5.2. Market Size and Forecast, by Application
6.4.6. China Opioids Market
6.4.6.1. Market Size and Forecast, by Product Type
6.4.6.2. Market Size and Forecast, by Application
6.4.7. Australia Opioids Market
6.4.7.1. Market Size and Forecast, by Product Type
6.4.7.2. Market Size and Forecast, by Application
6.4.8. India Opioids Market
6.4.8.1. Market Size and Forecast, by Product Type
6.4.8.2. Market Size and Forecast, by Application
6.4.9. South Korea Opioids Market
6.4.9.1. Market Size and Forecast, by Product Type
6.4.9.2. Market Size and Forecast, by Application
6.4.10. Rest of Asia-Pacific Opioids Market
6.4.10.1. Market Size and Forecast, by Product Type
6.4.10.2. Market Size and Forecast, by Application
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, by Product Type
6.5.3. Market Size and Forecast, by Application
6.5.4. Market Size and Forecast, by Country
6.5.5. Brazil Opioids Market
6.5.5.1. Market Size and Forecast, by Product Type
6.5.5.2. Market Size and Forecast, by Application
6.5.6. Saudi Arabia Opioids Market
6.5.6.1. Market Size and Forecast, by Product Type
6.5.6.2. Market Size and Forecast, by Application
6.5.7. South Africa Opioids Market
6.5.7.1. Market Size and Forecast, by Product Type
6.5.7.2. Market Size and Forecast, by Application
6.5.8. Rest of LAMEA Opioids Market
6.5.8.1. Market Size and Forecast, by Product Type
6.5.8.2. Market Size and Forecast, by Application
Chapter 7: Company Profiles
7.1. Boehringer Ingelheim Group
7.1.1. Company Overview
7.1.2. Key Executives
7.1.3. Company Snapshot
7.1.4. Operating Business Segments
7.1.5. Product Portfolio
7.1.6. Business Performance
7.1.7. Key Strategic Moves and Developments
7.2. Astrazeneca plc
7.2.1. Company Overview
7.2.2. Key Executives
7.2.3. Company Snapshot
7.2.4. Operating Business Segments
7.2.5. Product Portfolio
7.2.6. Business Performance
7.2.7. Key Strategic Moves and Developments
7.3. Endo Pharmaceuticals, Inc
7.3.1. Company Overview
7.3.2. Key Executives
7.3.3. Company Snapshot
7.3.4. Operating Business Segments
7.3.5. Product Portfolio
7.3.6. Business Performance
7.3.7. Key Strategic Moves and Developments
7.4. Johnson and Johnson
7.4.1. Company Overview
7.4.2. Key Executives
7.4.3. Company Snapshot
7.4.4. Operating Business Segments
7.4.5. Product Portfolio
7.4.6. Business Performance
7.4.7. Key Strategic Moves and Developments
7.5. Mallinckrodt plc
7.5.1. Company Overview
7.5.2. Key Executives
7.5.3. Company Snapshot
7.5.4. Operating Business Segments
7.5.5. Product Portfolio
7.5.6. Business Performance
7.5.7. Key Strategic Moves and Developments
7.6. Pfizer Inc
7.6.1. Company Overview
7.6.2. Key Executives
7.6.3. Company Snapshot
7.6.4. Operating Business Segments
7.6.5. Product Portfolio
7.6.6. Business Performance
7.6.7. Key Strategic Moves and Developments
7.7. Purdue Pharma L. P
7.7.1. Company Overview
7.7.2. Key Executives
7.7.3. Company Snapshot
7.7.4. Operating Business Segments
7.7.5. Product Portfolio
7.7.6. Business Performance
7.7.7. Key Strategic Moves and Developments
7.8. Sanofi
7.8.1. Company Overview
7.8.2. Key Executives
7.8.3. Company Snapshot
7.8.4. Operating Business Segments
7.8.5. Product Portfolio
7.8.6. Business Performance
7.8.7. Key Strategic Moves and Developments
7.9. Sun Pharmaceutical Industries Ltd
7.9.1. Company Overview
7.9.2. Key Executives
7.9.3. Company Snapshot
7.9.4. Operating Business Segments
7.9.5. Product Portfolio
7.9.6. Business Performance
7.9.7. Key Strategic Moves and Developments
7.10. Teva Pharmaceutical Industries Limited
7.10.1. Company Overview
7.10.2. Key Executives
7.10.3. Company Snapshot
7.10.4. Operating Business Segments
7.10.5. Product Portfolio
7.10.6. Business Performance
7.10.7. Key Strategic Moves and Developments